カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

10価肺炎球菌多糖体ワクチンの世界市場2022：単回投与バイアル、プレフィルドシリンジ

◆英語タイトル：Global 10-Valent Pneumococcal Polysaccharide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22DC3725）◆商品コード：GIR22DC3725
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年1月
◆ページ数：75
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の10価肺炎球菌多糖体ワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界の10価肺炎球菌多糖体ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

10価肺炎球菌多糖体ワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・単回投与バイアル、プレフィルドシリンジ

アプリケーション別セグメントは次のように区分されます。
・病院、診療所

世界の10価肺炎球菌多糖体ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・GSK

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、10価肺炎球菌多糖体ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な10価肺炎球菌多糖体ワクチンメーカーの企業概要、2019年～2022年までの10価肺炎球菌多糖体ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な10価肺炎球菌多糖体ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別10価肺炎球菌多糖体ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの10価肺炎球菌多糖体ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での10価肺炎球菌多糖体ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および10価肺炎球菌多糖体ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、10価肺炎球菌多糖体ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– 10価肺炎球菌多糖体ワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：単回投与バイアル、プレフィルドシリンジ
– 用途別分析（2017年vs2021年vs2028年）：病院、診療所
– 世界の10価肺炎球菌多糖体ワクチン市場規模・予測
– 世界の10価肺炎球菌多糖体ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– GSK
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：単回投与バイアル、プレフィルドシリンジ
・用途別分析2017年-2028年：病院、診療所
・10価肺炎球菌多糖体ワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・10価肺炎球菌多糖体ワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・10価肺炎球菌多糖体ワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・10価肺炎球菌多糖体ワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・10価肺炎球菌多糖体ワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 10-Valent Pneumococcal Polysaccharide Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Single Dose Vial
1.2.3 Pre-filled Syringe
1.3 Market Analysis by Application
1.3.1 Overview: Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.4 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size & Forecast
1.4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume (2017-2028)
1.4.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (2017-2028)
1.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity Analysis
1.5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Total Production Capacity (2017-2028)
1.5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 10-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
1.6.2 10-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
1.6.3 10-Valent Pneumococcal Polysaccharide Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product and Services
2.1.4 GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 10-Valent Pneumococcal Polysaccharide Vaccine Breakdown Data by Manufacturer
3.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in 10-Valent Pneumococcal Polysaccharide Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturer Market Share in 2021
3.5 Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and 10-Valent Pneumococcal Polysaccharide Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
4.1.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
4.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028)
4.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028)
4.4 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028)
4.5 South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028)
4.6 Middle East and Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Type (2017-2028)
5.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2028)
5.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Application (2017-2028)
6.2 Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2028)
6.3 Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
7.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
7.3 North America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
7.3.1 North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
8.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
8.3 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
8.3.1 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Region
9.3.1 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
10.2 South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
10.3 South America 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
10.3.1 South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
11.3.1 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of 10-Valent Pneumococcal Polysaccharide Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of 10-Valent Pneumococcal Polysaccharide Vaccine
12.3 10-Valent Pneumococcal Polysaccharide Vaccine Production Process
12.4 10-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 10-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
13.3 10-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Product and Services
Table 6. GSK 10-Valent Pneumococcal Polysaccharide Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in 10-Valent Pneumococcal Polysaccharide Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and 10-Valent Pneumococcal Polysaccharide Vaccine Production Site of Key Manufacturer
Table 12. 10-Valent Pneumococcal Polysaccharide Vaccine New Entrant and Capacity Expansion Plans
Table 13. 10-Valent Pneumococcal Polysaccharide Vaccine Mergers & Acquisitions in the Past Five Years
Table 14. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 15. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 16. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 19. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 20. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 21. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 24. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 25. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 26. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 27. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 28. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 29. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 30. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 31. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 32. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 33. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 34. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 35. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 36. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. 10-Valent Pneumococcal Polysaccharide Vaccine Raw Material
Table 71. Key Manufacturers of 10-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. 10-Valent Pneumococcal Polysaccharide Vaccine Typical Distributors
Table 75. 10-Valent Pneumococcal Polysaccharide Vaccine Typical Customers
List of Figures
Figure 1. 10-Valent Pneumococcal Polysaccharide Vaccine Picture
Figure 2. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type in 2021
Figure 3. Single Dose Vial
Figure 4. Pre-filled Syringe
Figure 5. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global 10-Valent Pneumococcal Polysaccharide Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. 10-Valent Pneumococcal Polysaccharide Vaccine Market Drivers
Figure 15. 10-Valent Pneumococcal Polysaccharide Vaccine Market Restraints
Figure 16. 10-Valent Pneumococcal Polysaccharide Vaccine Market Trends
Figure 17. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. 10-Valent Pneumococcal Polysaccharide Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 10-Valent Pneumococcal Polysaccharide Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global 10-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa 10-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of 10-Valent Pneumococcal Polysaccharide Vaccine in 2021
Figure 76. Manufacturing Process Analysis of 10-Valent Pneumococcal Polysaccharide Vaccine
Figure 77. 10-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 10価肺炎球菌多糖体ワクチンの世界市場2022：単回投与バイアル、プレフィルドシリンジ(Global 10-Valent Pneumococcal Polysaccharide Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 7価肺炎球菌ワクチンの世界市場2022：単回投与バイアル、プレフィルドシリンジ
  • 10価肺炎球菌結合型ワクチンの世界市場見通し2023年-2029年
  • 腸チフスVi多糖体ワクチンの世界市場2022：子供用、大人用

    • ◆H&Iグローバルリサーチのお客様（例）◆